These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15602099)

  • 41. The monoamine reuptake inhibitor milnacipran does not affect nociception to acute visceral distension in rats.
    Shin SW; Eisenach JC; Rao SG; Tong C
    Anesth Analg; 2004 May; 98(5):1365-9, table of contents. PubMed ID: 15105216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of milnacipran in the treatment of generalized anxiety disorder: an open study.
    Tsukamoto T; Kondoh R; Ichikawa K
    Int J Psychiatry Clin Pract; 2004; 8(4):255-8. PubMed ID: 24930555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Between depression and fibroniyalgia: the fate of the antidepressant].
    Drobizhev MY; Fedotova AV; Kikta SV; Antokhin EY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):114-120. PubMed ID: 27386594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life.
    Rouillon F; Berdeaux G; Bisserbe JC; Warner B; Mesbah M; Smadja C; Chwalow J
    J Affect Disord; 2000 Jun; 58(3):171-80. PubMed ID: 10802126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization and consequences of pain variability in individuals with fibromyalgia.
    Harris RE; Williams DA; McLean SA; Sen A; Hufford M; Gendreau RM; Gracely RH; Clauw DJ
    Arthritis Rheum; 2005 Nov; 52(11):3670-4. PubMed ID: 16258905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of milnacipran in treating phantom limb pain.
    Nagoshi Y; Watanabe A; Inoue S; Kuroda T; Nakamura M; Matsumoto Y; Fukui K
    Neuropsychiatr Dis Treat; 2012; 8():549-53. PubMed ID: 23185119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute hepatitis associated with milnacipran treatment].
    de Widerspach-Thor A; Dubois F; Bacq Y
    Gastroenterol Clin Biol; 2004 Feb; 28(2):191-2. PubMed ID: 15060467
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of phantom bite syndrome with milnacipran - a case series.
    Toyofuku A; Kikuta T
    Neuropsychiatr Dis Treat; 2006 Sep; 2(3):387-90. PubMed ID: 19412487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of Persistent Idiopathic Dentoalveolar Pain with Venlafaxine: A Multicentric Retrospective Study on Its Effectiveness and Safety.
    Xiao X; Chai G; Wang B; Luo F
    J Pain Res; 2023; 16():2487-2495. PubMed ID: 37497373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous ejaculation with the use of noradrenergic reuptake inhibitors.
    Oosterhuis I; Heijting L; van Puijenbroek E
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1461-2. PubMed ID: 22441314
    [No Abstract]   [Full Text] [Related]  

  • 51. Marked effect of milnacipran combined with olanzapine for a delusional depressive patient.
    Sugawara Y; Higuchi H; Yoshida K; Shimizu T
    Neuropsychiatr Dis Treat; 2005 Dec; 1(4):373-4. PubMed ID: 18568118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excessive sweating in a male patient caused by milnacipran.
    Shinohara Y
    Indian J Psychiatry; 2009 Apr; 51(2):162. PubMed ID: 19823644
    [No Abstract]   [Full Text] [Related]  

  • 53. A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease.
    Marks DM; Pae CU; Patkar AA
    Prim Care Companion CNS Disord; 2014; 16(4):. PubMed ID: 25664215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study.
    Marks DM; Bolognesi MP
    Prim Care Companion CNS Disord; 2013; 15(4):. PubMed ID: 24392250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current evidence on atypical odontalgia: diagnosis and clinical management.
    Abiko Y; Matsuoka H; Chiba I; Toyofuku A
    Int J Dent; 2012; 2012():518548. PubMed ID: 22844283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Literature mining for the discovery of hidden connections between drugs, genes and diseases.
    Frijters R; van Vugt M; Smeets R; van Schaik R; de Vlieg J; Alkema W
    PLoS Comput Biol; 2010 Sep; 6(9):. PubMed ID: 20885778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.
    Higuchi T; Briley M
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):41-58. PubMed ID: 19300537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of milnacipran for the treatment of chronic pain: a case series.
    Kamata M; Takahashi H; Naito S; Higuchi H
    Clin Neuropharmacol; 2004; 27(5):208-10. PubMed ID: 15602099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of milnacipran in the treatment of chronic pain syndromes.
    Kamata M; Naito S; Higuchi H; Suzuki A; Otani K
    Int J Psychiatry Clin Pract; 2010 Mar; 14(1):68-71. PubMed ID: 24917235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Milnacipran dose-effect study in patients with burning mouth syndrome.
    Kato Y; Sato T; Katagiri A; Umezaki Y; Takenoshita M; Yoshikawa T; Sato Y; Toyofuku A
    Clin Neuropharmacol; 2011; 34(4):166-9. PubMed ID: 21738023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.